Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Patent
1996-09-13
2000-04-11
Mach, D. Margaret M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
562586, 562598, 562600, A01N 3700, C07C 5900, C07C 5702, C07C 5142
Patent
active
060488972
ABSTRACT:
Compounds having the active site of natural lipoxins, but a longer tissue half-life are disclosed. In particular, 15-epi-lipoxins and their use in ameliorating undesired cell proliferation, which characterizes diseases such as cancer, are also disclosed.
REFERENCES:
patent: 4560514 (1985-12-01), Samuelsson et al.
patent: 4576758 (1986-03-01), Morris
patent: 5049681 (1991-09-01), Sato
patent: 5079261 (1992-01-01), Serhan et al.
Fiore, et al. "Lipoxin Recognition Sites", The Journal of Biological Chemistry (1992), vol. 267, No. 23, pp. 16168-16176.
Claria, J. et al., "Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions" Proc. Nat'l Acad. Sci., vol. 92 pp. 9475-9479 (1995).
Serhan, "Lipoxins: Eicosanoids Carrying Intra-and Intercellular Messages", Journal of Bioenergetics and Biomembranes, (1991), vol. 23, No. 1, pp. 105-122.
Mizukami, et al., ".omega.-Hydroxylation of lipoxin B.sub.4 by human neutrophil microsomes: identification of .omega.-hydroxy metabolite of lipoxin B.sub.4 and catalysis by leukotriene B.sub.4 .omega.-hydroxylase (cytochrome P-450LTB.omega.)", Biochimica et Biophysica Acta (1993), No. 1168, pp. 87-93.
Popov, et al., "Effect of Lipoxin B on Colony-Forming Ability of Human Peripheral Blood Mononuclears in a Diffusion Chambers", Translated from Byulleten' Eksperimental' noi Biologii i Meditsiny, (1989), vol. 107, No. 1, pp. 80-83.
Katoh, et al., "Renal Hemodynamic Actions of Lipoxin in Rats: A Comparative Physiological Study", American Journal Physiology, (1992), vol. 263, pp. F436-F442.
Nigam, et al., "Lipoxin A.sub.4 and Lipoxin B.sub.4 Stimulate the Release but Not the Oxygenation of Arachidonic Acid in Human Neutrophils: Dissociation between Lipid Remodeling and Adhesion", Journal of Cellular Physiology, (1990), vol. 143, pp. 512-523.
Lee, et al., "Inhibition of Leukotriene B.sub.4 -Induced Neutrophil Migration by Lipoxin A.sub.4 : Structure-Function Relationships", Biochemical and Biophysical Research Communications, (1991), vol. 180, No. 3, pp. 1416-1421.
Nicolaou, et al., "Lipoxins and Related Eicosanoids: Biosynthesis, Biological Properties, and Chemical Synthesis", Angew, Chem. Int. Ed. Engl., (1991), vol. 30, pp. 1100-1116.
Nicolaou, et al., "Identification of a Novel 7-cis-11-trans-lipoxin A.sub.4 Generated by Human Neutrophils: Total Synthesis, Spasmogenic Activities and Comparison with Other Geometric Isomers of Lipoxin A.sub.4 and B.sub.4 ", Biochimica et Biophysica Acta, (1989), No. 1003, pp. 44-53.
Nicolaou, et al., "Total Synthesis of Novel Geometric Isomers of Lipoxin A.sub.4 and Lipoxin B.sub.4 ", Reprint from The Journal of Organic Chemistry (1989), vol. 54, No. 23, pp. 5527-5535.
Brady, et al., "Leukotrienes Stimulate Neutrophil Adhesion to Mesangial Cells: Modulation with Lipoxins", American Journal Physiology, (1990), vol. 259, pp. F809-F815.
Brigham and Women's Hospital
M. Mach D. Margaret
Rothenberger Scott D.
LandOfFree
Lipoxin compounds and their use in treating cell proliferative d does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Lipoxin compounds and their use in treating cell proliferative d, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Lipoxin compounds and their use in treating cell proliferative d will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1177138